首页> Cell death & disease> CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer.

CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer.

导出 OA

翻译打印收藏纠错

第一作者： Cong,Xiang

第一单位： Department of Obstetrics and Gynecology, Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), Chongqing, China.

作者： Cong,Xiang ^[1] ; Li,Chen ^[1] ; Shilei,Zhu ^[2] ; Yue,Chen ^[1] ; Haodong,Huang ^[1] ; Chunmao,Yang ^[3] ; Yugang,Chi ^[1] ; Yanzhou,Wang ^[3] ; Yunlong,Lei ^[4] ; Xiongwei,Cai ^[5]

作者单位： Department of Obstetrics and Gynecology, Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), Chongqing, China. ^[1] Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, China. ^[2] Department of Gynecology, Southwest Hospital, Chongqing, China. ^[3] Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.;Molecular Medicine and Cancer Research Center, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. ^[4] Department of Obstetrics and Gynecology, Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), Chongqing, China. xiongweicai@126.com. ^[5]